|
The report comprehensively analyzes the current status, pain points, opportunities, and future trends of the industry
Landmark Industry Report Unveils Future of China’s Aquaculture Sector
CHINA
Thursday, January 08, 2026, 07:00 (GMT + 9)
Market Value Hits $3.58 Billion as Green Tech and International Expansion Signal New Era for Veterinary Drugs and Water Conditioning
BEIJING – On December 29, 2025, the industry reached a significant milestone with the official release of the "Report on the Development Status of China's Aquaculture Veterinary Drugs and Water Conditioning Products Industry (2025)". As the first systematic research of its kind, the Report provides a data-driven roadmap for the future of aquatic health and environmental management.
Market Dynamics and Regional Dominance
According to the findings, the total market size for fish medicines and water conditioning products in China remained stable at approximately 25 billion yuan ($3.58 billion USD) in 2024. The market is bifurcated into two primary segments:
The Report highlights a high geographical concentration, with Central China, East China, and South China emerging as the core consumption hubs. These three regions represent more than 75% of national sales, aligning perfectly with China's major aquaculture production zones.
Guo Jian, Secretary-General of the Fisheries Medicine and Water Control Products Branch of the China Fisheries Association, interprets the report -->
Industry Structure and Leading Players
The sector is currently characterized by a "concentration among leaders" alongside a fragmented landscape of smaller players. Key statistics from the China Fisheries Association’s Veterinary Drugs and Water Treatment Supplies Branch include:
-
204 member companies surveyed, including 195 manufacturers.
-
Hubei, Jiangsu, and Guangdong provinces host over 47% of these firms.
-
Leading companies dominate the landscape, capturing more than 70% of total industry sales, with top-tier performers exceeding 1 billion yuan ($143 million USD) in annual revenue.
Addressing Challenges and Regulatory Gaps
Despite the robust market size, the Report identifies critical "pain points" that hinder progress:
-
Regulatory Gaps: A lack of high-level legal constraints for water conditioning products.
-
Product Shortages: China currently has only 133 national standard veterinary drugs, leading to a deficit in "green" medicinal options.
-
R&D Lag: Many small and medium-sized enterprises lack independent research teams, resulting in technological innovation that fails to keep pace with the needs of sustainable aquaculture.
The Path to 2030: Growth and Innovation
The future looks bright for enterprises willing to pivot toward high-end technology. The Report projects:
-
15% Annual Growth: Expected in the high-end product market over the next 3 to 5 years.
-
20% Export Growth: Anticipated annually over the next 5 years, specifically targeting markets in Southeast Asia, Africa, and South America.
Li Qing, Vice President of the China Fisheries Association, emphasized that the industry must shift from a "price war" to a "value war." By adhering to the new "Quality and Safety Production Management Standard for Aquaculture Water Conditioning Products" (T/SCFA 0022—2025), the sector aims to ensure the safety of aquatic products and the stability of the ecosystem.
[email protected]
www.seafood.media
|